DeepMed Research

PHARMAZZ, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2010-01-01

Employees: 51

Market Cap: -

Website: http://www.pharmazz.com

Clinical Trials

A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients

Phase 4

Recruiting

Conditions: Hypovolemic Shock

Interventions: Drug: Centhaquine

First Posted Date: 2023-07-21

Last Posted Date: 2025-05-13

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 400

Registration Number: NCT05956418

Locations: 🇮🇳
KG Hospital, Coimbatore, Tamil Nadu, India
🇮🇳
Aman Hospital, Vadodara, Gujarat, India
🇮🇳
Dayanand Medical College & Hospital (DMCH), Ludhiāna, Punjab, India

and more 14 locations

Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Phase 4

Recruiting

Conditions: Acute Cerebral Ischemia

Interventions: Other: Normal Saline
Drug: Sovateltide

First Posted Date: 2023-07-21

Last Posted Date: 2025-05-13

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 160

Registration Number: NCT05955326

Locations: 🇮🇳
Government Medical College and attached Hospitals, Kota, Rajasthan, India
🇮🇳
KG Hospital and Post Graduate Medical Institute, Coimbatore, Tamil Nadu, India
🇮🇳
Radiant Superspeciality Hospital, Amaravati, Maharashtra, India

and more 3 locations

Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

Phase 3

Not yet recruiting

Conditions: Acute Ischemic Stroke
Cerebral Stroke

Interventions: Drug: Sovateltide

First Posted Date: 2023-01-19

Last Posted Date: 2025-05-14

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 514

Registration Number: NCT05691244

Locations: 🇺🇸
CHI Memorial Neuroscience Institute, Chattanooga, Tennessee, United States
🇩🇪
Klinikum Altenburger Land GmbH, Altenburg, Germany
🇩🇪
Rhon-Klinikum Campus Bad Neustadt, Bad Neustadt a.d. Saale, Germany

and more 3 locations

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

Phase 2

Recruiting

Conditions: Hypoxic-Ischemic Encephalopathy
Neonatal Asphyxia
Neonatal Encephalopathy

Interventions: Drug: Normal Saline along with standard treatment
Drug: Sovateltide along with standard treatment

First Posted Date: 2022-08-24

Last Posted Date: 2025-05-12

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 40

Registration Number: NCT05514340

Locations: 🇮🇳
Father Muller Medical College Hospital, Mangalore, Karnataka, India
🇮🇳
Niloufer Hospital, Hyderabad, Telangana, India
🇮🇳
GSVM Medical College, Kanpur, Uttar Pradesh, India

and more 1 locations

A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Phase 3

Not yet recruiting

Conditions: Hypovolemic Shock

Interventions: Drug: Normal Saline
Drug: Centhaquine

First Posted Date: 2022-02-22

Last Posted Date: 2023-06-22

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 430

Registration Number: NCT05251181

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS

Phase 2

Not yet recruiting

Conditions: COVID-19 Acute Respiratory Distress Syndrome

Interventions: Drug: Centhaquine
Drug: Normal Saline

First Posted Date: 2022-02-15

Last Posted Date: 2023-06-22

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 60

Registration Number: NCT05241067

PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock

Phase 2

Completed

Conditions: Blood Loss
Hypovolemic Shock

Interventions: Drug: Centhaquine
Drug: Normal Saline

First Posted Date: 2019-08-14

Last Posted Date: 2019-08-14

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 50

Registration Number: NCT04056065

Locations: 🇮🇳
KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre, Belgaum, India
🇮🇳
Dayanand Medical College & Hospital, Ludhiana, India
🇮🇳
ORIANA Hospital, Varanasi, India

and more 4 locations

PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury

Phase 2

Recruiting

Conditions: Acute Spinal Cord Injury

Interventions: Drug: Normal Saline along with standard treatment
Drug: PMZ-1620 along with standard treatment

First Posted Date: 2019-08-13

Last Posted Date: 2023-07-11

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 40

Registration Number: NCT04054414

Locations: 🇮🇳
Rahate Surgical Hospital & ICU, Nagpur, India
🇮🇳
Institute of Postgraduate Medical Education & Research and SSKM Hospital, Kolkata, India
🇮🇳
Indian Spinal Injury Centre, New Delhi, India

and more 2 locations

PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer Disease
Dementia

Interventions: Drug: Normal Saline along with standard treatment
Drug: PMZ-1620 (sovateltide) along with standard treatment

First Posted Date: 2019-08-12

Last Posted Date: 2023-01-12

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 80

Registration Number: NCT04052737

Locations: 🇮🇳
King George's Medical University, Lucknow, India
🇮🇳
Post Graduate Institute of Medical Education and Research, Chandigarh, India
🇮🇳
Seth GSMC & KEM Hospital, Mumbai, India

and more 2 locations

Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke

Phase 3

Completed

Conditions: Cerebral Infarction
Cerebral Ischemia
Stroke, Acute

Interventions: Drug: Normal Saline along with standard treatment
Drug: PMZ-1620 (sovateltide) along with standard treatment

First Posted Date: 2019-08-06

Last Posted Date: 2023-10-18

Lead Sponsor: Pharmazz, Inc.

Target Recruit Count: 158

Registration Number: NCT04047563

Locations: 🇮🇳
Post Graduate Institute of Medical Education and Research, Chandigarh, India
🇮🇳
Pushpanjali Hospital & Research Centre Pvt. Ltd, Agra, Uttar Pradesh, India
🇮🇳
New Era Hospital & Research Institute, Nagpur, India

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy